Golvatinib

An orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor) and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with potential antineoplastic activity. c-Met/VEGFR kinase inhibitor E7050 binds to and inhibits the activities of both c-Met and VEGFR-2, which may inhibit tumor cell growth and survival of tumor cells that overexpress these receptor tyrosine kinases. c-Met and VEGFR-2 are upregulated in a variety of tumor cell types and play important roles in tumor cell growth, migration and angiogenesis. (NCI Thesaurus)

YOU MAY ALSO LIKE

Golotimod

An orally bioavailable synthetic peptide containing the amino acids D-glutamine and L-tryptophan connected by a gamma-glutamyl linkage with potential immunostimulating, antimicrobial and…

Golnerminogene Pradenovec

A recombinant agent consisting of a genetically-modified adenovirus 5 vector encoding the protein cytokine tumor necrosis factor (TNF) alpha. TNF exhibits potent…

GOLM1 wt Allele

Human GOLM1 wild-type allele is located in the vicinity of 9q21.33 and is approximately 74 kb in length. This allele, which encodes…

GOLM1 Gene

This gene is involved in both the trafficking and posttranslational modification of proteins.

Golimumab

A human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity. Golimumab binds to TNF-a, thereby preventing…

GOLIM4 wt Allele

Human GOLIM4 wild-type allele is located in the vicinity of 3q26.2 and is approximately 87 kb in length. This allele, which encodes…